Published on in Vol 4, No 2 (2015): Apr-Jun

Timing of High-Dose Rate Brachytherapy With External Beam Radiotherapy in Intermediate and High-Risk Localized Prostate CAncer (THEPCA) Patients and Its Effects on Toxicity and Quality of Life: Protocol of a Randomized Feasibility Trial

Timing of High-Dose Rate Brachytherapy With External Beam Radiotherapy in Intermediate and High-Risk Localized Prostate CAncer (THEPCA) Patients and Its Effects on Toxicity and Quality of Life: Protocol of a Randomized Feasibility Trial

Timing of High-Dose Rate Brachytherapy With External Beam Radiotherapy in Intermediate and High-Risk Localized Prostate CAncer (THEPCA) Patients and Its Effects on Toxicity and Quality of Life: Protocol of a Randomized Feasibility Trial

Journals

  1. Roy A, Brenneman R, Hogan J, Barnes J, Huang Y, Morris R, Goddu S, Altman M, Garcia-Ramirez J, Li H, Zoberi J, Bullock A, Kim E, Smith Z, Figenshau R, Andriole G, Baumann B, Michalski J, Gay H. Does the sequence of high-dose rate brachytherapy boost and IMRT for prostate cancer impact early toxicity outcomes? Results from a single institution analysis. Clinical and Translational Radiation Oncology 2021;29:47 View
  2. Winter R, Amghar M, Wacker A, Bakos G, Taş H, Roscher M, Kelly J, Benešová-Schäfer M. Future Treatment Strategies for Cancer Patients Combining Targeted Alpha Therapy with Pillars of Cancer Treatment: External Beam Radiation Therapy, Checkpoint Inhibition Immunotherapy, Cytostatic Chemotherapy, and Brachytherapy. Pharmaceuticals 2024;17(8):1031 View

Books/Policy Documents

  1. Folkert M, Desai N, Yamada Y. Smith's Textbook of Endourology. View
  2. Harris A, Stang K, Harkenrider M, Kamrava M, Lock D, Morton G, Mysz M, Showalter T, Wong A, Solanki A. Radiation Therapy for Genitourinary Malignancies. View